NEW DELHI : Pharma major Sun Pharmaceutical Industries on Wednesday reported a 37.12% decline in its consolidated net profit to ₹399.84 crore for the quarter ended March 2020, mainly on account of one time exceptional loss.
The company had posted a net profit of ₹635.88 crore in the same period previous fiscal, Sun Pharma said in a BSE filing.
Consolidated revenue from operations stood at ₹8,184.94 crore for the quarter under consideration as against ₹7,163.92 crore in the same period a year ago, it added.
The company had a one-time exceptional loss of ₹260.64 crore in the quarter ended March 2020, the filing said.
For the fiscal ended March 2020, the net profit of the company was at ₹3,764.93 crore as against ₹2,665.42 crore in the previous fiscal, Sun Pharma said.
The revenue from operations for the fiscal ended March this year stood at ₹32,837.50 crore. It was ₹29,065.91 crore the year-ago fiscal, it added.
The board has recommended payment of dividend of Re 1 per equity share of Re 1 each for the year ended March 31, 2020, Sun Pharma said.
Shares of Sun Pharmaceutical Industries were closed at Rs 450.55 per scrip on the BSE, down 1.85% from its previous close.
Click here to read the Mint ePaper Livemint.com is now on Telegram. Join Livemint channel in your Telegram and stay updated
